Moderna wins FDA approval for expanded use of RSV shot in more adults

A little more than a week after Moderna’s new Covid-19 vaccine was approved, the FDA has expanded who can receive the company’s RSV shot. The agency approved mResvia on Thursday for at-risk adults aged 18 ...